Wip1 regulates SKOV3 cell apoptosis through the p38 MAPK signaling pathway

Yanping Feng1, Fang Liu1, Zhixiang Du1

  • 1Department of Reproductive Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei 050031, P.R. China.

Insights

Silencing wild-type p53-induced phosphatase 1 (Wip1) in ovarian cancer cells significantly increased apoptosis. This suggests targeting Wip1 could be a future therapeutic strategy for ovarian cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Ovarian cancer remains a leading cause of cancer-related deaths globally.
  • Understanding the molecular mechanisms regulating cancer cell apoptosis is crucial for developing novel therapies.
  • Wild-type p53-induced phosphatase 1 (Wip1) is implicated in various cellular processes, including DNA repair and cell cycle regulation.

Purpose of the Study:

  • To investigate the effect of silencing Wip1 on apoptosis in human ovarian cancer SKOV3 cells.
  • To elucidate the molecular pathways involved in Wip1-mediated regulation of apoptosis.
  • To assess the potential of Wip1 as a therapeutic target in ovarian cancer.

Main Methods:

  • SKOV3 cells were treated with small interfering RNA (siRNA) targeting Wip1 or control siRNA.
  • Flow cytometry was used to quantify apoptosis.
  • Western blot and RT-qPCR were employed to analyze the expression of key proteins and mRNAs involved in apoptosis signaling pathways, including p53, caspase-3, Bax, Bcl-2, and p38 MAPK.

Main Results:

  • Wip1 silencing significantly enhanced apoptosis in SKOV3 cells compared to controls.
  • Silencing Wip1 led to increased expression of p53 and phosphorylated p38 MAPK.
  • Elevated cleaved caspase-3/caspase-3 and Bax/Bcl-2 protein ratios were observed following Wip1 knockdown.

Conclusions:

  • Wip1 silencing promotes apoptosis in human ovarian cancer cells.
  • The pro-apoptotic effect is mediated by the activation of p38 MAPK signaling pathways and subsequent upregulation of p53.
  • Targeting Wip1 represents a promising therapeutic strategy for human ovarian cancer.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.3K